Cargando…

Head and Neck Cancer During Covid-19 Pandemic: Was there a Diagnostic Delay?

The aim of the present study is to investigate a possible delay in diagnosis and therapy administration for Head and Neck oncological patients, during the Sars-Cov2 pandemic and to compare the median tumor stage (MTS) at presentation. This is a retrospective review on patients who presented at the U...

Descripción completa

Detalles Bibliográficos
Autores principales: Lucidi, Daniela, Valerini, Sara, Federici, Gaia, Miglio, Matteo, Cantaffa, Carla, Alicandri-Ciufelli, Matteo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer India 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760594/
https://www.ncbi.nlm.nih.gov/pubmed/35070919
http://dx.doi.org/10.1007/s12070-021-03050-5
_version_ 1784633355817451520
author Lucidi, Daniela
Valerini, Sara
Federici, Gaia
Miglio, Matteo
Cantaffa, Carla
Alicandri-Ciufelli, Matteo
author_facet Lucidi, Daniela
Valerini, Sara
Federici, Gaia
Miglio, Matteo
Cantaffa, Carla
Alicandri-Ciufelli, Matteo
author_sort Lucidi, Daniela
collection PubMed
description The aim of the present study is to investigate a possible delay in diagnosis and therapy administration for Head and Neck oncological patients, during the Sars-Cov2 pandemic and to compare the median tumor stage (MTS) at presentation. This is a retrospective review on patients who presented at the University Hospital of Modena with a newly diagnosis of Head and Neck cancer (HNC), comparing the first pandemic period (from March 1st, to October 15th 2020) to the same period of 2019. The time in days from the diagnostic suspicion to the beginning of the treatment, hereafter referred to as delay in treatment initiation (DTI), and the tumor stage were calculated for all the enrolled patients. Mean percentage of reduction of the clinical and surgical activities was − 25.8% (range: − 66–1.5%), with higher percentages in phase 1 for all the analyzed activities. 125 HNC patients were enrolled in the analysis as the study group, compared with a cohort of 140 patients from the previous year. The MTS was III for both groups, however a significant statistical difference was determined in the stage comparison, p = 0.023. When DTI was analyzed no statistically significant differences were appreciated. A more advanced stage at presentation was demonstrated at our institution for HNC patients during the first phase of the Covid-19 pandemic in 2020. However, a statistically significant delay in time between diagnosis and therapy administration was not assessed, thus confirming the maintenance of a high level of care even in the COVID-19 era.
format Online
Article
Text
id pubmed-8760594
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer India
record_format MEDLINE/PubMed
spelling pubmed-87605942022-01-18 Head and Neck Cancer During Covid-19 Pandemic: Was there a Diagnostic Delay? Lucidi, Daniela Valerini, Sara Federici, Gaia Miglio, Matteo Cantaffa, Carla Alicandri-Ciufelli, Matteo Indian J Otolaryngol Head Neck Surg Original Article The aim of the present study is to investigate a possible delay in diagnosis and therapy administration for Head and Neck oncological patients, during the Sars-Cov2 pandemic and to compare the median tumor stage (MTS) at presentation. This is a retrospective review on patients who presented at the University Hospital of Modena with a newly diagnosis of Head and Neck cancer (HNC), comparing the first pandemic period (from March 1st, to October 15th 2020) to the same period of 2019. The time in days from the diagnostic suspicion to the beginning of the treatment, hereafter referred to as delay in treatment initiation (DTI), and the tumor stage were calculated for all the enrolled patients. Mean percentage of reduction of the clinical and surgical activities was − 25.8% (range: − 66–1.5%), with higher percentages in phase 1 for all the analyzed activities. 125 HNC patients were enrolled in the analysis as the study group, compared with a cohort of 140 patients from the previous year. The MTS was III for both groups, however a significant statistical difference was determined in the stage comparison, p = 0.023. When DTI was analyzed no statistically significant differences were appreciated. A more advanced stage at presentation was demonstrated at our institution for HNC patients during the first phase of the Covid-19 pandemic in 2020. However, a statistically significant delay in time between diagnosis and therapy administration was not assessed, thus confirming the maintenance of a high level of care even in the COVID-19 era. Springer India 2022-01-15 2022-10 /pmc/articles/PMC8760594/ /pubmed/35070919 http://dx.doi.org/10.1007/s12070-021-03050-5 Text en © Association of Otolaryngologists of India 2022
spellingShingle Original Article
Lucidi, Daniela
Valerini, Sara
Federici, Gaia
Miglio, Matteo
Cantaffa, Carla
Alicandri-Ciufelli, Matteo
Head and Neck Cancer During Covid-19 Pandemic: Was there a Diagnostic Delay?
title Head and Neck Cancer During Covid-19 Pandemic: Was there a Diagnostic Delay?
title_full Head and Neck Cancer During Covid-19 Pandemic: Was there a Diagnostic Delay?
title_fullStr Head and Neck Cancer During Covid-19 Pandemic: Was there a Diagnostic Delay?
title_full_unstemmed Head and Neck Cancer During Covid-19 Pandemic: Was there a Diagnostic Delay?
title_short Head and Neck Cancer During Covid-19 Pandemic: Was there a Diagnostic Delay?
title_sort head and neck cancer during covid-19 pandemic: was there a diagnostic delay?
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760594/
https://www.ncbi.nlm.nih.gov/pubmed/35070919
http://dx.doi.org/10.1007/s12070-021-03050-5
work_keys_str_mv AT lucididaniela headandneckcancerduringcovid19pandemicwasthereadiagnosticdelay
AT valerinisara headandneckcancerduringcovid19pandemicwasthereadiagnosticdelay
AT federicigaia headandneckcancerduringcovid19pandemicwasthereadiagnosticdelay
AT migliomatteo headandneckcancerduringcovid19pandemicwasthereadiagnosticdelay
AT cantaffacarla headandneckcancerduringcovid19pandemicwasthereadiagnosticdelay
AT alicandriciufellimatteo headandneckcancerduringcovid19pandemicwasthereadiagnosticdelay